University of Copenhagen
Copenhagen, 1165, Denmark
NCT Number: NCT01317264
The aim of this study is to investigate the potential disease preventive effects of β-glucans from oat and barley.
Looking for future studies?
Notify Me18 year–40 year
All sexes
Interventional
Not applicable
Copenhagen, 1165, Denmark
Objective:
The primary aim is to examine whether consumption of oat and two different barley β-glucans exhibits hypocholesterolemic effects and to understand the underlying mechanisms.
Secondary aims are to investigate whether there are also effects on blood pressure, appetite regulation, insulin sensitivity, hemostasis, low-grade inflammation and the metabolic profile of different biological materials.
Intervention:
In each of the 4 intervention periods the participants drink a milk drink together with their three main meals for 21 days. This way they consume 5g β-glucan/d form either oat or barley in the three treatment periods, otherwise they maintain their habitual diet. They are not, however, allowed to eat any oat- or barley-containing products during the trial.
At the beginning and at the end of each intervention period the participants' blood pressure is measured and a fasting blood sample is drawn.
Further they collect feces for 72 hours and urine for 24 hours before and at the end of each intervention period.
Before and at the end of each intervention period a 4-hour meal test is undertaken to measure their subject appetite sensation. Here at first a fasting blood samples drawn and thereafter the milk drink is served. Appetite sensation is assessed every 30 min for 4 hours. Also blood samples are drawn at 2 hours and 4 hours at the meal tests which takes place before each intervention period.
At the subsequent "ad libitum" lunch meal the food intake is measured and then a final appetite registration is made.
Furthermore participants make 4-d food records before and at the end of each intervention period.
Healthy volunteers accepted: Yes
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
daily consumption of non-β-glucan containing milk drinks together with the 3 main meals for 21 days
daily consumption of 5g of oat β-glucan in the form of milk drinks with the 3 main meals for 21 days
Other names: "PromOat",Biovelop, Kimstad, Sweden
daily consumption of 5g β-glucan extracted from the barley-mutant mother "Bomi" in the form of milk drinks with the 3 main meals for 21 days
daily consumption of 5g β-glucan extracted from the high β-glucan barely mutant "lys. 5.f" in the form of milk drinks with the 3 main meals for 21 days
Time frame: fasting blood sample at baseline and day 21
Time frame: average over three days at baseline and after 3 weeks
Time frame: at baseline and after 1, 2 and 3 weeks
Time frame: at baseline and after 3 weeks
Time frame: at baseline
Time frame: fasting blood sample at baseline and on day 21
Time frame: 3h appetite registrations at baseline and on day 21
Time frame: at baseline and after 3 weeks
Time frame: average over 3 days at baseline and after 3 weeks
Time frame: at baseline and on day 21
University of Copenhagen
Other
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT06068257
Breast Cancer, Breast Diseases
Orlando, Florida, United States
View Trial DetailsNCT06702423
Healthy
London, United Kingdom
View Trial DetailsNCT07223164
Healthy
Irvine, California, United States
View Trial DetailsNCT05595902
Healthy
Kadıköy, Istanbul, Turkey (Türkiye)
View Trial Details